1. Home
  2. JNVR vs LGVN Comparison

JNVR vs LGVN Comparison

Compare JNVR & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JNVR
  • LGVN
  • Stock Information
  • Founded
  • JNVR 2018
  • LGVN 2014
  • Country
  • JNVR United States
  • LGVN United States
  • Employees
  • JNVR N/A
  • LGVN N/A
  • Industry
  • JNVR Finance: Consumer Services
  • LGVN Medicinal Chemicals and Botanical Products
  • Sector
  • JNVR Finance
  • LGVN Health Care
  • Exchange
  • JNVR Nasdaq
  • LGVN Nasdaq
  • Market Cap
  • JNVR 8.9M
  • LGVN 7.8M
  • IPO Year
  • JNVR 2023
  • LGVN 2021
  • Fundamental
  • Price
  • JNVR $0.75
  • LGVN $3.44
  • Analyst Decision
  • JNVR
  • LGVN Strong Buy
  • Analyst Count
  • JNVR 0
  • LGVN 1
  • Target Price
  • JNVR N/A
  • LGVN $12.00
  • AVG Volume (30 Days)
  • JNVR 1.0M
  • LGVN 14.9M
  • Earning Date
  • JNVR 07-16-2024
  • LGVN 08-09-2024
  • Dividend Yield
  • JNVR N/A
  • LGVN N/A
  • EPS Growth
  • JNVR N/A
  • LGVN N/A
  • EPS
  • JNVR N/A
  • LGVN N/A
  • Revenue
  • JNVR $1,947,052.00
  • LGVN $978,000.00
  • Revenue This Year
  • JNVR N/A
  • LGVN $137.24
  • Revenue Next Year
  • JNVR N/A
  • LGVN $50.77
  • P/E Ratio
  • JNVR N/A
  • LGVN N/A
  • Revenue Growth
  • JNVR N/A
  • LGVN N/A
  • 52 Week Low
  • JNVR $0.70
  • LGVN $0.77
  • 52 Week High
  • JNVR $5.50
  • LGVN $37.50
  • Technical
  • Relative Strength Index (RSI)
  • JNVR 48.47
  • LGVN 55.56
  • Support Level
  • JNVR N/A
  • LGVN N/A
  • Resistance Level
  • JNVR $1.01
  • LGVN $6.40
  • Average True Range (ATR)
  • JNVR 0.09
  • LGVN 0.52
  • MACD
  • JNVR -0.02
  • LGVN 0.06
  • Stochastic Oscillator
  • JNVR 65.62
  • LGVN 54.47

About JNVR Janover Inc.

Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Share on Social Networks: